Relapsing Aspergillus bronchitis in a double lung transplant patient, successfully treated with a new oral antimycotic agent

Chest

Volumn 111, Issue 3, 1997, Pages 835-836

  Harari, S ^a   Schiraldi, G ^a   De Juli, E ^a   Gronda, E ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AZATHIOPRINE; CYCLOSPORIN A; ITRACONAZOLE; STEROID; TERBINAFINE; THYMOCYTE ANTIBODY;

ASPERGILLUS FUMIGATUS; CHICKENPOX; GRAFT REJECTION; HUMAN; LETTER; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030900538     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.3.835     Document Type: Article

References (5)

1. Paradis IL Williams P Infections after lung transplantation Semin Respir Infect 8(3) 1993 207 215
2. Kramer MR Denning DW Marshall SE Ulcerative tracheobronchitis after lung transplantation A new form of invasive aspergillosis. Am Rev Respir Dis 144 1991 552 556
3. Nevin M Katz PF Pierce RA Liposomal Amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient J Heart Transplant 9 1990 14 17
4. Petranyi G Meingassner JG Mieth H Antifungal activity of the allylamine derivate terbinafine in vitro Antimicrob Agents Chemother 31 1987 1365 1368
5. Schiraldi GF Colombo MD Harari S Terbinafine in the treatment of non immunocompromised compassionate cases of bronchopulmonary aspergillosis Mycoses 39 1996 5 12